The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
VOICE trial: Final results from multicenter phaseII study of assessment of clinical efficiency and safety in capecitabine plus intermittent oxaliplatin together with bevacizumab as first-line therapy for patients with advanced colorectal cancer.
 
Chihiro Kosugi
No Relationships to Disclose
 
Keiji Koda
No Relationships to Disclose
 
Tadamichi Denda
Research Funding - Sanofi (Inst)
 
Keiichiro Ishibashi
No Relationships to Disclose
 
Hideyuki Ishida
No Relationships to Disclose
 
Kazuhiro Seike
No Relationships to Disclose
 
Naoto Sakata
No Relationships to Disclose
 
Shinji Yanagisawa
No Relationships to Disclose
 
Akinari Miyazaki
No Relationships to Disclose
 
Wataru Takayama
No Relationships to Disclose
 
Naoto Koike
No Relationships to Disclose
 
Hisahiro Matsubara
No Relationships to Disclose
 
Masato Yamazaki
No Relationships to Disclose
 
Hiroaki Shimizu
No Relationships to Disclose
 
Kiyohiko Shuto
No Relationships to Disclose
 
Mikito Mori
No Relationships to Disclose
 
Kazuo Narushima
No Relationships to Disclose